PROTOCOL IM011055: A Multi-center, Randomized, Double-blind,
Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of
Deucravacitinib in Participants with Active Psoriatic Arthritis (PsA) who are
Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or had Previously
Received TNFα Inhibitor Treatment
Clinicaltrial.gov website:
https://clinicaltrials.gov/ct2/show/NCT04908189?cond=Psoriatic+Arthritis&cntry=US&s
tate=US%3AMN&city=Eagan&draw=2&rank=4
PROTOCOL TILD-19-07 A Phase III, Randomized, Double-Blind, Placebo-
Controlled Study to Demonstrate the Efficacy and Safety of Tildrakizumab in
Anti-TNF Experienced Subjects with Active Psoriatic Arthritis I (INSPIRE 1)
Study Website:
Clinicaltrial.gov website:
https://clinicaltrials.gov/ct2/show/NCT04991116
PROTOCOL VTX958 A Phase 2, Multicenter, Randomized, Double-Blind,
Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of
VTX958 in Patients with Active Psoriatic Arthritis
VTX958 versus Placebo for the Treatment of Active Psoriatic Arthritis VTX958-203
Study Website:
https://ventyxbio.com/pipeline/
Clinicatrial.gov website:
https://www.clinicaltrials.gov/ct2/show/NCT05715125
PROTOCOL SOLSTICE PSA-3005 A Phase 3B, Multicenter, Randomized,
Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of
Guselkumab Administered Subcutaneously in Participants With Active Psoriatic
Arthritis Who Had an Inadequate Response and/or Intolerance to One Prior Anti-
Tumor Necrosis Factor Alpha Agent
Clinicatrial.gov Website:
https://www.clinicaltrials.gov/ct2/show/NCT04936308?recrs=a&cond=Psoriatic+Art
hritis&cntry=US&state=US%3AMN&city=Eagan&draw=2&rank=5
PROTOCOL STAR PSA4002 A Phase 4, Multicenter, Randomized, Double-
blind, Placebo-controlled Study Evaluating the Efficacy and Safety of
Guselkumab Administered Subcutaneously in Bio-naive Participants With Active
Psoriatic Arthritis Axial Disease
Clinicaltrial.gov website:
https://www.clinicaltrials.gov/ct2/show/NCT04929210?recrs=a&cond=Psoriatic+Arthriti
s&cntry=US&state=US%3AMN&city=Eagan&draw=2&rank=6